A big step for MYC-targeted therapies.
Trends Cancer
; 10(5): 383-385, 2024 May.
Article
em En
| MEDLINE
| ID: mdl-38580534
ABSTRACT
The MYC proto-oncogene encodes a master transcriptional regulator that is frequently dysregulated in human cancer. Decades of efforts have failed to identify a MYC-targeted therapeutic, and this is still considered to be a holy grail in drug development. We highlight a recent report by Garralda et al. of a Phase 1 clinical trial of OMO-103 in patients with solid malignancies.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Proteínas Proto-Oncogênicas c-myc
/
Terapia de Alvo Molecular
/
Proto-Oncogene Mas
/
Neoplasias
Limite:
Humans
Idioma:
En
Revista:
Trends Cancer
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos